Skip to main content

Advertisement

Log in

Decreased Expression of BRCA2 Accelerates Sporadic Breast Cancer Progression

  • ORIGINAL ARTICLE
  • Published:
Indian Journal of Surgical Oncology Aims and scope Submit manuscript

Abstract

Human tumor suppressor BRCA2 has been known to function in the repair of DNA double strand break. Germ line mutation in BRCA genes predisposes individuals to familial breast and ovarian cancer. The aim of present study was to characterize the implication of BRCA2 expression in cases of non − hereditary (sporadic) breast cancer. Female breast cancer patients aged between 20 and 75 years who underwent surgery were randomly selected. Patients with Stage IV disease at time of primary diagnosis or previous history of any other malignancy other than breast carcinoma or undergoing neoadjuvant chemotherapy were excluded from the study. Total 48 patients full filled these criteria. Patients were treated with either modified radical mastectomy or breast conservation therapy. Concentration of BRCA2 was measured by Sandwiched method of ELISA. Immunohistochemistry was used to determine the hormonal receptor status. Stage of the disease was not found to have any significant correlation on the BRCA2 expression. In patients with higher grade of tumors the level of BRCA2 expression was found to be low. Decreased expression of BRCA2 was found to be triple negative, had aggressive features and associated with higher chances of axillary metastasis. Genetic instability caused by decreased expression of BRCA2 could trigger mutations in sporadic breast cancer cases and mutations in turn leads to uncontrolled proliferation and invasive growth.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

DNA:

De-oxy ribonucleic acid

BRCA:

Breast cancer susceptibility protein

ATM/ATR:

Ataxia telangiectasia mutated/ataxia telangiectasia and Rad3-related protein

TP53:

tumor protein 53

CHK2:

checkpoint kinase-2

Rad51:

Rad51 recombinase

ER:

Estrogen receptor

PR:

Progesterone receptor

HER2:

Human epidermal growth factor receptor protein 2

USG:

Ultrasonography

MRI:

Magnetic resonance imaging

ELISA:

Enzyme linked immunosorbent assay

References

  1. Goldhirsch A et al (1998) Meeting highlights: international consensus panel on the treatment of primary breast cancer. J Natl Cancer Inst 90(21):1601–1608

    Article  CAS  PubMed  Google Scholar 

  2. McGuire WL (1991) Breast cancer prognostic factors: evaluation guidelines. J Natl Cancer Inst 83(3):154–155

    Article  CAS  PubMed  Google Scholar 

  3. Panel, N.I.o.H.C.D. (2001) National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1–3, 2000. J National Cancer Institute. 93(13): p. 979–989

  4. DeVita, V.T.L., Theodore S.; Rosenberg, Steven A, Devita, Hellman & Rosenberg’s Cancer: Principles & Practice of Oncology. 18th Edition: p. 1600

  5. Chen J et al (1998) Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells. Mol Cell 2(3):317–328

    Article  CAS  PubMed  Google Scholar 

  6. Scully R et al (1999) Genetic analysis of BRCA1 function in a defined tumor cell line. Mol Cell 4(6):1093–1099

    Article  CAS  PubMed  Google Scholar 

  7. Shinohara A, Ogawa H, Ogawa T (1992) Rad51 protein involved in repair and recombination in S. cerevisiae is a RecA-like protein. Cell 69(3):457–470

    Article  CAS  PubMed  Google Scholar 

  8. Baumann P, Benson FE, West SC (1996) Human Rad51 protein promotes ATP-dependent homologous pairing and strand transfer reactions in vitro. Cell 87(4):757–766

    Article  CAS  PubMed  Google Scholar 

  9. Sung P (1994) Catalysis of ATP-dependent homologous DNA pairing and strand exchange by yeast RAD51 protein. Science 265(5176):1241–1243

    Article  CAS  PubMed  Google Scholar 

  10. Venkitaraman AR (2001) Functions of BRCA1 and BRCA2 in the biological response to DNA damage. J Cell Sci 114(20):3591–3598

    CAS  PubMed  Google Scholar 

  11. Moynahan ME, Cui TY, Jasin M (2001) Homology-directed dna repair, mitomycin-c resistance, and chromosome stability is restored with correction of a Brca1 mutation. Cancer Res 61(12):4842–4850

    CAS  PubMed  Google Scholar 

  12. Couch FJ, W.B. (2002) Breast cancer: The genetic basis of human cancer. . Vogelstein B, Kinzler KW, eds. New York: McGraw-Hill, NY: p. 549–581

  13. Thompson ME et al (1995) Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat Genet 9(4):444–450

    Article  CAS  PubMed  Google Scholar 

  14. Yoshida K, Miki Y (2004) Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage. Cancer Sci 95(11):866–871

    Article  CAS  PubMed  Google Scholar 

  15. Veronica P et al (2000) Gross chromosomal rearrangements and genetic exchange between nonhomologous chromosomes following BRCA2 inactivation. Genes Dev 14(11):1400–1406

    Google Scholar 

  16. Chappuis PO, V Nethercot, WD Foulkes (2000) Clinico–pathological characteristics of BRCA1†and BRCA2†related breast cancer. in Seminars in surgical oncology. Wiley Online Library

  17. Scully R et al (1997) Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88(2):265–275

    Article  CAS  PubMed  Google Scholar 

  18. Jana D et al (2012) Prognostic significance of HER-2/neu and survival of breast cancer patients attending a specialized breast clinic in Kolkata, Eastern India. Asian Pac J Cancer Prev 13:3851–3855

    Article  PubMed  Google Scholar 

  19. Onitilo AA et al (2009) Breast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survival. Clin Med Res 7(1–2):4–13

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Marmorstein LY et al (2001) A human BRCA2 complex containing a structural DNA binding component influences cell cycle progression. Cell 104(2):247–257

    Article  CAS  PubMed  Google Scholar 

  21. Greenblatt MS et al (2001) TP53 Mutations in breast cancer associated with BRCA1 or BRCA2 germ-line mutations distinctive spectrum and structural distribution. Cancer Res 61(10):4092–4097

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Authors are indebted to the Director and the H.O.D. of our departmen for providing the infrastructural facilities. We must express our obligation and gratitude to the Institutional Ethical Committee for their kind permission to carry out this study in this Hospital/Institute. We are also grateful to the funding body, Govt. of West Bengal, Department of Science & Technology. We also thanks to our patients for their continuing co-operation.

Conflict of Interest

All authors have declared no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Soumi Saha or Diptendra Kumar Sarkar.

Additional information

Soumi Saha and Pranab Mandal contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Saha, S., Mandal, P., Ganguly, S. et al. Decreased Expression of BRCA2 Accelerates Sporadic Breast Cancer Progression. Indian J Surg Oncol 6, 378–383 (2015). https://doi.org/10.1007/s13193-015-0449-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13193-015-0449-1

Keywords

Navigation